CLINICAL_TRIALS
trial_result
· 2016-01-28
Clinical Trial Update: Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study [Phase 3]
Summary
Phase 3 trial update reporting completed study and posted results for a protein kinase C inhibitor in diabetic retinopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chromaderm, Inc. | Conditions: Diabetic Retinopathy | Phase 3 | Status: COMPLETED | Results posted: 2016-01-28